Abstract:Hilar cholangiocarcinoma has been a subject of major interest in the IHPBA ever since its founding, with many members who have emerged as leading experts in the management of this difficult tumour. This thematic issue of HPB addresses some of the current issues in the surgical treatment of hilar cholangiocarcinoma. The first contribution, from New York, deals with preoperative evaluation and assessment of resectability of hilar cholangiocarcinoma. The Bismuth–Corlette classification is based on proximal extent of the tumour into the biliary tree, but does not take into account vascular involvement. The authors therefore propose an alternative, clinical staging system based on biliary ductal involvement, vascular involvement and lobar atrophy. The paper from Paris points out the need for optimal preoperative preparation of patients with hilar cholangiocarcinoma considered for resection. Although preoperative biliary decompression is controversial, it probably is important in patients with hilar cholangiocarcinoma requiring extended liver resection in order to allow postoperative or preoperative regeneration of the liver, the latter in the setting of preoperative portal vein embolization to induce hypertrophy of the future liver remnant. Resectional strategies in the treatment of hilar cholangiocarcinoma are discussed in the contribution from Houston. Resection of the portal vein bifurcation in conjunction with hilar resection potentially increases the rate ofmargin-negative resections, but as the authors emphasize, is not routinely recommended in the absence of signs of portal vein invasion. The authors from Nagoya, who pioneered resection of hilar cholangiocarcinoma with extended liver resections three decades ago, show that in recent years, thesemajor resections have been performed with a mortality rate of 55% and a 5-year survival rate of 27% (in R0 resections). They also show that patients resected with regional lymph node metastases still have a better survival than unresected patients. In a study from Amsterdam, it is shown that complete excision of segment 1 with resection of hilar cholangiocarcinoma leads to a higher rate of R0 resections and improves survival without increasingmorbidity ormortality. The current status of liver transplantation in the treatment of hilar cholangiocarcinoma is reviewed in the paper from Essen. The place of liver transplantation needs to be reconsidered in the light of recent, promising results of neoadjuvant therapies in selected patients. Surgical palliative treatment of hilar cholangiocarcinoma is addressed in the contribution from Edinburgh. Relief of pruritus or cholangitis is the main indication for biliary drainage, and most experience to date concerns segment III cholangio-jejunostomy as a biliary bypass procedure. Although favourable results have been reported for intrahepatic ductal bypass, it remains to be seen whether these procedures can compete with percutaneous stenting techniques. A review from Indianapolis addresses the role of radiation and chemotherapy in hilar cholangiocarcinoma. Whereas the benefit of radiation or chemotherapy alone is questionable, chemoradiation seems the way to go but awaits further clinical assessment in controlled trials. It gives the editors of HPB great pleasure to present in this issue a true update on the surgical management of hilar cholangiocarcinoma, at the same time showing the vast experience with this tumour shared in the IHPBA.

Architecture and public health: from harmful designs to healthy built environments

The relationship of urban design to human health and condition

Urban Design and Mental Health

Healthy buildings for a healthy city: Is the public health evidence base informing current building policies?

Health by design; optimising our urban environmental microbiomes for human health

INTEGRATING HEALTH INTO BUILDINGS OF THE FUTURE

After Covid-19: urban design as spatial medicine

Build Healthier: Post-COVID-19 Urban Requirements for Healthy and Sustainable Living

How to Estimate Forecasting Quality: A System- Motivated Derivation of Symmetric Mean Absolute Percentage Error (SMAPE) and Other Similar Characteristics

Transforming building industry and health outcomes through social data-supported design

Role of Built Environments on Physical Activity and Health Promotion: A Review and Policy Insights

Symposium on hilar cholangiocarcinoma.

A conceptual analysis of the public health-architecture nexus within rapidly developing informal urban contexts

[The municipal planning for the benefit of health]

Building Resilient Cities: Climate Change and Health Interlinkages in the Planning of Public Spaces

Promoting health and advancing development through improved housing in low-income settings

Built Environment And Public Health Review And Planning In North American Metropolitan Areas

Green Buildings: Human-Centered and Energy Efficiency Optimization Strategies

Healthy Design and Urban Planning Strategies, Actions, and Policy to Achieve Salutogenic Cities

Shared decision making in designing new healthcare environments—time to begin improving quality

New trends in urban environmental health research: from geography of diseases to therapeutic landscapes and healing gardens